Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas

Lung Cancer

Volumn 41, Issue 2, 2003, Pages 163-169

  Wu, Tzu Chin ^b   Lin, Pinpin ^a   Hsu, Chung Ping ^c   Huang, Yi Jie ^a   Chen, Chih Yi ^c   Chung, Wen Chuan ^a   Lee, Huei ^a   Ko, Jiunn Liang ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Lung cancer; Telomerase; TRAP

Indexed keywords

ISOENZYME; PROTEIN P53; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBUNIT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0037829204     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00195-8     Document Type: Article

References (18)

1. Howe H.L., Wingo P.A., Thun M.J., et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl. Cancer Inst. 93:2001;824-842.
2. Singh G.K., Miller B.A., Hankey B.F. Changing area socioeconomic patterns in US cancer mortality, 1950-1998: part II - lung and colorectal cancers. J. Natl. Cancer Inst. 94:2002;916-925.
3. Wigle D.A., Jurisica I., Radulovich N., et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res. 62:2002;3005-3008.
4. Kim N.W., Piatyszek M.A., Prowse K.R., et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
5. Rubin H. The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat. Biotechnol. 20:2002;675-681.
6. Falchetti M.L., Levi A., Molinari P., et al. Increased sensitivity and reproducibility of TRAP assay by avoiding direct primers interaction. Nucleic Acids Res. 26:1998;862-863.
7. Lingner J., Hughes T.R., Shevchenko A., et al. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science. 276:1997;561-567.
8. Hara T., Noma T., Yamashiro Y., et al. Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma. Urol. Res. 29:2001;1-6.
9. Devereux T.R., Horikawa I., Anna C.H., et al. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res. 59:1999;6087-6090.
10. Arinaga M., Shimizu S., Gotoh K., et al. Expression of human telomerase subunit genes in primary lung cancer and its clinical significance. Ann. Thorac. Surg. 70:2000;401-405. discussion 405-406.
11. Taga S., Osaki T., Ohgami A., et al. Prognostic impact of telomerase activity in non-small cell lung cancers. Ann. Surg. 230:1999;715-720.
12. Dickson M.A., Hahn W.C., Ino Y., et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20:2000;1436-1447.
13. Hayflick L. The illusion of cell immortality. Br. J. Cancer. 83:2000;841-846.
14. Wisman G.B., Knol A.J., Helder M.N., et al. Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer. Int. J. Cancer. 91:2001;658-664.
15. Li H., Zhao L.L., Funder J.W., et al. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem. 272:1997;16729-16732.
16. Yu C.C., Lo S.C., Wang T.C. Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells. Biochem. J. 355:2001;459-464.
17. Kang S.S., Kwon T., Kwon D.Y., et al. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 274:1999;13085-13090.
18. Xu D., Wang Q., Gruber A., et al. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene. 19:2000;5123-5133.